CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JPMORGAN CHASE & CO | 69,907 | $102,064 | 0.00% |
Citadel Advisors | 31,300 | $45,698 | 0.00% |
Citadel Advisors | 17,100 | $24,966 | 0.00% |
Citadel Advisors | 183 | $267 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,800 | $24,528 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 53,400 | $77,964 | 0.00% |
VANGUARD GROUP INC | 1,346,932 | $1,966,521 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,232 | $16,399 | 0.00% |
HRT FINANCIAL LP | 13,050 | $19 | 0.00% |
SIMPLEX TRADING, LLC | 39,493 | $57 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 127,968 | $186,833 | 0.00% |
UBS Group AG | 6,700 | $9,782 | 0.00% |
COMMERCE BANK | 20,000 | $29,200 | 0.00% |
RHUMBLINE ADVISERS | 791 | $1,154 | 0.00% |
IFP Advisors, Inc | 24 | $35 | 0.00% |
BARCLAYS PLC | 13,682 | $20 | 0.00% |
OSAIC HOLDINGS, INC. | 2,400 | $3,504 | 0.00% |
External links
This page lists CORVUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view CORVUS PHARMACEUTICALS INC's shareholder history, click here.